|
1
|
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.
|
J Clin Oncol
|
2001
|
1.58
|
|
2
|
A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.
|
Proc Natl Acad Sci U S A
|
1996
|
0.96
|
|
3
|
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours.
|
Br J Cancer
|
2011
|
0.88
|
|
4
|
Inhibition of coagulation by a phosphorothioate oligonucleotide.
|
Antisense Nucleic Acid Drug Dev
|
1997
|
0.87
|
|
5
|
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome.
|
J Clin Pharmacol
|
1999
|
0.77
|
|
6
|
Oxygenation during perfluorocarbon associated gas exchange in normal and abnormal lungs.
|
Artif Cells Blood Substit Immobil Biotechnol
|
1994
|
0.75
|
|
7
|
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
|
J Clin Pharmacol
|
2000
|
0.75
|